Viewing Study NCT05877820


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2025-12-26 @ 3:13 AM
Study NCT ID: NCT05877820
Status: RECRUITING
Last Update Posted: 2023-08-31
First Post: 2023-05-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC
Sponsor: RenJi Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module